555 related articles for article (PubMed ID: 22119554)
1. TRPA1 antagonists as potential analgesic drugs.
Andrade EL; Meotti FC; Calixto JB
Pharmacol Ther; 2012 Feb; 133(2):189-204. PubMed ID: 22119554
[TBL] [Abstract][Full Text] [Related]
2. Sustained TRPA1 activation in vivo.
Koivisto A
Acta Physiol (Oxf); 2012 Feb; 204(2):248-54. PubMed ID: 21518269
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the biology and medicinal chemistry of TRPA1.
Rech JC; Eckert WA; Maher MP; Banke T; Bhattacharya A; Wickenden AD
Future Med Chem; 2010 May; 2(5):843-58. PubMed ID: 21426205
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential ion channels: powerful regulators of cell function.
Billeter AT; Hellmann JL; Bhatnagar A; Polk HC
Ann Surg; 2014 Feb; 259(2):229-35. PubMed ID: 23989052
[TBL] [Abstract][Full Text] [Related]
5. Activation of transient receptor potential ankyrin 1 by eugenol.
Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
[TBL] [Abstract][Full Text] [Related]
6. 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
Baraldi PG; Romagnoli R; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Pedretti P; Fusi C; Nassini R; Materazzi S; Geppetti P; Preti D
Bioorg Med Chem; 2012 Mar; 20(5):1690-8. PubMed ID: 22325155
[TBL] [Abstract][Full Text] [Related]
7. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
[TBL] [Abstract][Full Text] [Related]
8. The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives.
Nassini R; Fusi C; Materazzi S; Coppi E; Tuccinardi T; Marone IM; De Logu F; Preti D; Tonello R; Chiarugi A; Patacchini R; Geppetti P; Benemei S
Br J Pharmacol; 2015 Jul; 172(13):3397-411. PubMed ID: 25765567
[TBL] [Abstract][Full Text] [Related]
9. Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.
Gijsen HJ; Berthelot D; De Cleyn MA; Geuens I; Brône B; Mercken M
Bioorg Med Chem Lett; 2012 Jan; 22(2):797-800. PubMed ID: 22222037
[TBL] [Abstract][Full Text] [Related]
10. Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.
Copeland KW; Boezio AA; Cheung E; Lee J; Olivieri P; Schenkel LB; Wan Q; Wang W; Wells MC; Youngblood B; Gavva NR; Lehto SG; Geuns-Meyer S
Bioorg Med Chem Lett; 2014 Aug; 24(15):3464-8. PubMed ID: 24953819
[TBL] [Abstract][Full Text] [Related]
11. A new tr(i)p to sense pain: TRPA1 channel as a target for novel analgesics.
Cai X
Expert Rev Neurother; 2008 Nov; 8(11):1675-81. PubMed ID: 18986238
[TBL] [Abstract][Full Text] [Related]
12. TRPA1 modulators in preclinical development.
Viana F; Ferrer-Montiel A
Expert Opin Ther Pat; 2009 Dec; 19(12):1787-99. PubMed ID: 19939193
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy.
Koivisto A; Hukkanen M; Saarnilehto M; Chapman H; Kuokkanen K; Wei H; Viisanen H; Akerman KE; Lindstedt K; Pertovaara A
Pharmacol Res; 2012 Jan; 65(1):149-58. PubMed ID: 22133672
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential ankyrin 1: emerging pharmacology and indications for cardiovascular biology.
Bodkin JV; Brain SD
Acta Physiol (Oxf); 2011 Sep; 203(1):87-98. PubMed ID: 20950342
[TBL] [Abstract][Full Text] [Related]
15. Transient receptor potential channels on sensory nerves.
Eid SR; Cortright DN
Handb Exp Pharmacol; 2009; (194):261-81. PubMed ID: 19655110
[TBL] [Abstract][Full Text] [Related]
16. The TRPA1 channel in migraine mechanism and treatment.
Benemei S; Fusi C; Trevisan G; Geppetti P
Br J Pharmacol; 2014 May; 171(10):2552-67. PubMed ID: 24206166
[TBL] [Abstract][Full Text] [Related]
17. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
Niforatos W; Zhang XF; Lake MR; Walter KA; Neelands T; Holzman TF; Scott VE; Faltynek CR; Moreland RB; Chen J
Mol Pharmacol; 2007 May; 71(5):1209-16. PubMed ID: 17314320
[TBL] [Abstract][Full Text] [Related]
18. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity.
Eid SR; Crown ED; Moore EL; Liang HA; Choong KC; Dima S; Henze DA; Kane SA; Urban MO
Mol Pain; 2008 Oct; 4():48. PubMed ID: 18954467
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
Nakao S; Mabuchi M; Wang S; Kogure Y; Shimizu T; Noguchi K; Tanaka A; Dai Y
Bioorg Med Chem Lett; 2017 Jul; 27(14):3167-3172. PubMed ID: 28576617
[TBL] [Abstract][Full Text] [Related]
20. 2-Amino-4-arylthiazole compounds as TRPA1 antagonists (WO 2012085662): a patent evaluation.
De Petrocellis L; Schiano Moriello A
Expert Opin Ther Pat; 2013 Jan; 23(1):119-47. PubMed ID: 23126422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
